Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Ahern

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Journal of the American College of Surgeons|March 3, 2018
Post-Discharge Opioid Prescribing and Use after Common Surgical ProcedureMayo H Fujii, Ashley C Hodges, Ruby L Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Modification of tamoxifen response: what have we learned?Timothy L Lash, Thomas P Ahern, Deirdre Cronin-Fenton, et al.
Breast Cancer Research and Treatment|September 20, 2024
Genetic variants and social benefit receipt in premenopausal women with breast cancer treated with docetaxel: a Danish population-based cohort studyJulie A Schmidt, Cathrine F Hjorth, Dóra K Farkas, et al.
Plos One|February 6, 2014
Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysisDeirdre P Cronin-Fenton, Mariann Christensen, Timothy L Lash, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2020
Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatinThomas P Ahern, Per Damkier, Søren Feddersen, et al.
Breast Cancer Research : BCR|April 8, 2024
Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patientsKirsten M Woolpert, Julie A Schmidt, Thomas P Ahern, et al.
Radiology. Imaging Cancer|April 5, 2024
Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide RegistryBrian L Sprague, Sarah A Nowak, Thomas P Ahern, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2011
Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer studyDeirdre P Cronin-Fenton, Ylva Hellberg, Kristina L Lauridsen, et al.
Breast Cancer Research and Treatment|May 2, 2022
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in DenmarkCathrine F Hjorth, Per Damkier, Tore B Stage, et al.
Clinical Epidemiology|April 22, 2025
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus PlaceboSigne Borgquist, Maj-Britt Jensen, Cecilie Linea Bendorff, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Journal of the American College of Surgeons|March 3, 2018
Post-Discharge Opioid Prescribing and Use after Common Surgical ProcedureMayo H Fujii, Ashley C Hodges, Ruby L Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Modification of tamoxifen response: what have we learned?Timothy L Lash, Thomas P Ahern, Deirdre Cronin-Fenton, et al.
Breast Cancer Research and Treatment|September 20, 2024
Genetic variants and social benefit receipt in premenopausal women with breast cancer treated with docetaxel: a Danish population-based cohort studyJulie A Schmidt, Cathrine F Hjorth, Dóra K Farkas, et al.
Plos One|February 6, 2014
Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysisDeirdre P Cronin-Fenton, Mariann Christensen, Timothy L Lash, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2020
Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatinThomas P Ahern, Per Damkier, Søren Feddersen, et al.
Breast Cancer Research : BCR|April 8, 2024
Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patientsKirsten M Woolpert, Julie A Schmidt, Thomas P Ahern, et al.
Radiology. Imaging Cancer|April 5, 2024
Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide RegistryBrian L Sprague, Sarah A Nowak, Thomas P Ahern, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2011
Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer studyDeirdre P Cronin-Fenton, Ylva Hellberg, Kristina L Lauridsen, et al.
Breast Cancer Research and Treatment|May 2, 2022
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in DenmarkCathrine F Hjorth, Per Damkier, Tore B Stage, et al.
Clinical Epidemiology|April 22, 2025
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus PlaceboSigne Borgquist, Maj-Britt Jensen, Cecilie Linea Bendorff, et al.
Pageof 11